Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Dubée V[au]:

Search results

Items: 48

1.

Are three blood culture sets really necessary for all febrile patients? Commentary on 'Estimation of missed bloodstream infections without the third blood culture set: a retrospective observational single-centre study,' Collazos-Blanco A et al., Clin Microbiol Infect 2019;25:469-473.

Mahieu R, Pailhoriès H, Kouatchet A, Dubée V.

Clin Microbiol Infect. 2019 Jul 12. pii: S1198-743X(19)30400-8. doi: 10.1016/j.cmi.2019.07.011. [Epub ahead of print] No abstract available.

PMID:
31306795
2.

The prognosis of streptococcal prosthetic bone and joint infections depends on surgical management-A multicenter retrospective study.

Mahieu R, Dubée V, Seegers V, Lemarié C, Ansart S, Bernard L, Le Moal G, Asseray N, Arvieux C, Ramanantsoa C, Cormier H, Legrand E, Abgueguen P; CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest) Study Team.

Int J Infect Dis. 2019 Aug;85:175-181. doi: 10.1016/j.ijid.2019.06.012. Epub 2019 Jun 15.

3.

Colistin-glycopeptide combinations against multidrug-resistant Acinetobacter baumannii in a mouse model of pneumonia.

Sanderink D, Cassisa V, Chenouard R, Mahieu R, Kempf M, Dubée V, Eveillard M.

Future Microbiol. 2019 May;14:581-586. doi: 10.2217/fmb-2019-0022. Epub 2019 Jun 7.

PMID:
31172805
4.

Tryptophan Fluorescence Quenching in β-Lactam-Interacting Proteins Is Modulated by the Structure of Intermediates and Final Products of the Acylation Reaction.

Triboulet S, Edoo Z, Compain F, Ourghanlian C, Dupuis A, Dubée V, Sutterlin L, Atze H, Etheve-Quelquejeu M, Hugonnet JE, Arthur M.

ACS Infect Dis. 2019 Jul 12;5(7):1169-1176. doi: 10.1021/acsinfecdis.9b00023. Epub 2019 May 14.

PMID:
31056908
5.

Epidemiology of infective endocarditis in French intensive care units over the 1997-2014 period-from CUB-Réa Network.

Joffre J, Dumas G, Aegerter P, Dubée V, Bigé N, Preda G, Baudel JL, Maury E, Guidet B, Ait-Oufella H; CUB-Réa Network.

Crit Care. 2019 Apr 25;23(1):143. doi: 10.1186/s13054-019-2387-8.

6.

Negative Impact of Carbapenem Methylation on the Reactivity of β-Lactams for Cysteine Acylation as Revealed by Quantum Calculations and Kinetic Analyses.

Bhattacharjee N, Triboulet S, Dubée V, Fonvielle M, Edoo Z, Hugonnet JE, Ethève-Quelquejeu M, Simorre JP, Field MJ, Arthur M, Bougault CM.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02039-18. doi: 10.1128/AAC.02039-18. Print 2019 Apr.

7.

Topical rapamycin (sirolimus) for treatment of cutaneous microcystic lymphatic malformation of the gluteal area.

Leducq S, Vrignaud S, Lorette G, Herbreteau D, Dubee V, Martin L, Maruani A.

Eur J Dermatol. 2019 Feb 1;29(1):82-83. doi: 10.1684/ejd.2018.3440. No abstract available.

PMID:
30530427
8.

The Weaning Index combining EtCO2 and respiratory rate early identifies Spontaneous Breathing Trial failure.

Baudel JL, Dubee V, Boelle PY, Bourcier S, Leblanc G, Joffre J, Bigé N, Preda G, Dumas G, Guidet B, Maury E, Ait-Oufella H.

Minerva Anestesiol. 2019 Apr;85(4):384-392. doi: 10.23736/S0375-9393.18.13108-7. Epub 2018 Nov 22.

PMID:
30482002
9.

Tissue perfusion alterations correlate with mortality in patients admitted to the intensive care unit for acute pulmonary embolism: An observational study.

Urbina T, Bigé N, Nguyen Y, Boelle PY, Dubée V, Joffre J, Abdallah I, Baudel JL, Maury E, Guidet B, Ait-Oufella H.

Medicine (Baltimore). 2018 Oct;97(42):e11993. doi: 10.1097/MD.0000000000011993.

10.

Functional outcomes in adults with tuberculous meningitis admitted to the ICU: a multicenter cohort study.

Cantier M, Morisot A, Guérot E, Megarbane B, Razazi K, Contou D, Mariotte E, Canet E, De Montmollin E, Dubée V, Boulet E, Gaudry S, Voiriot G, Mayaux J, Pène F, Neuville M, Mourvillier B, Ruckly S, Bouadma L, Wolff M, Timsit JF, Sonneville R; ENCEPHALITICA study group.

Crit Care. 2018 Aug 17;22(1):210. doi: 10.1186/s13054-018-2140-8.

11.

On the Nose: Disseminated Mucormycosis.

Danneels P, Mahieu R, Dib M, Abgueguen P, Rabier V, Klosek M, Le Govic Y, Dubée V.

Am J Med. 2018 Oct;131(10):1182-1184. doi: 10.1016/j.amjmed.2018.05.008. Epub 2018 May 26. No abstract available.

PMID:
29806997
12.

Reversible Microvascular Hyporeactivity to Acetylcholine During Diabetic Ketoacidosis.

Joffre J, Bourcier S, Hariri G, Miailhe AF, Bigé N, Dumas G, Dubée V, Boelle PY, Abdallah I, Baudel JL, Guidet B, Maury E, Ait-Oufella H.

Crit Care Med. 2018 Aug;46(8):e772-e778. doi: 10.1097/CCM.0000000000003224.

PMID:
29782357
13.

Increased mortality in patients aged 75 years or over with pyogenic vertebral osteomyelitis.

Zarrouk V, Gras J, Dubée V, de Lastours V, Lopes A, Leflon V, Allaham W, Guigui P, Fantin B.

Infect Dis (Lond). 2018 Oct;50(10):783-787. doi: 10.1080/23744235.2018.1470667. Epub 2018 May 10. No abstract available.

PMID:
29745282
14.

Nasotracheal intubation in ICU: an unfairly forgotten procedure.

Hariri G, Baudel JL, Dubee V, Dumas G, Joffre J, Bourcier S, Bige N, Ait Oufella H, Maury E.

Minerva Anestesiol. 2018 Aug;84(8):997-998. doi: 10.23736/S0375-9393.18.12655-1. Epub 2018 Mar 27. No abstract available.

15.

In vitro activity of tedizolid against the Mycobacterium abscessus complex.

Compain F, Soroka D, Heym B, Gaillard JL, Herrmann JL, Dorchène D, Arthur M, Dubée V.

Diagn Microbiol Infect Dis. 2018 Mar;90(3):186-189. doi: 10.1016/j.diagmicrobio.2017.11.001. Epub 2017 Nov 10.

PMID:
29217419
16.

Penicillin G susceptibility in Staphylococcus aureus is not so infrequent.

Moraly J, Dahoumane R, Dubée V, Preda G, Baudel JL, Joffre J, Bigé N, Ait-Oufella H, Maury E.

Minerva Anestesiol. 2018 Jan;84(1):123-124. doi: 10.23736/S0375-9393.17.12153-X. Epub 2017 Sep 11. No abstract available.

17.

Iterative Fecal Microbiota Transplantations for Eradicating Digestive Colonization With Carbapenemase-Producing Enterobacteriaceae: Is It Worth It?

Mahieu R, Cassisa V, Sanderink D, Chenouard R, Pailhoriès H, Kempf M, Dubée V, Eveillard M.

Infect Control Hosp Epidemiol. 2017 Oct;38(10):1265-1266. doi: 10.1017/ice.2017.173. Epub 2017 Aug 15. No abstract available.

PMID:
28807067
18.

Marked regional endothelial dysfunction in mottled skin area in patients with severe infections.

Bourcier S, Joffre J, Dubée V, Preda G, Baudel JL, Bigé N, Leblanc G, Levy BI, Guidet B, Maury E, Ait-Oufella H.

Crit Care. 2017 Jun 23;21(1):155. doi: 10.1186/s13054-017-1742-x.

19.

Are third-generation cephalosporins unavoidable for empirical therapy of community-acquired pneumonia in adult patients who require ICU admission? A retrospective study.

Hariri G, Tankovic J, Boëlle PY, Dubée V, Leblanc G, Pichereau C, Bourcier S, Bigé N, Baudel JL, Galbois A, Ait-Oufella H, Maury E.

Ann Intensive Care. 2017 Dec;7(1):35. doi: 10.1186/s13613-017-0259-4. Epub 2017 Mar 24.

20.

Mottling score is associated with 28-day mortality in critically ill patients with sepsis.

Preda G, Bourcier S, Joffre J, Boelle PY, Dubee V, Baudel JL, Bige N, Guidet B, Maury E, Ait-Oufella H.

Minerva Anestesiol. 2017 Jun;83(6):664-666. doi: 10.23736/S0375-9393.17.11816-X. Epub 2017 Jan 25. No abstract available.

21.

Inhibition of β-lactamases of mycobacteria by avibactam and clavulanate.

Soroka D, Ourghanlian C, Compain F, Fichini M, Dubée V, Mainardi JL, Hugonnet JE, Arthur M.

J Antimicrob Chemother. 2017 Apr 1;72(4):1081-1088. doi: 10.1093/jac/dkw546.

PMID:
28039278
22.

Use of a needle-guided device to facilitate axillary vein cannulation.

Bigé N, Dubée V, Alves M, Pichereau C, Bourcier S, Joffre J, Preda G, Baudel JL, Galbois A, Ait-Oufella H, Maury E.

Minerva Anestesiol. 2017 Jan;83(1):102-103. doi: 10.23736/S0375-9393.16.11398-7. Epub 2016 Jul 19. No abstract available.

23.

Toe-to-room temperature gradient correlates with tissue perfusion and predicts outcome in selected critically ill patients with severe infections.

Bourcier S, Pichereau C, Boelle PY, Nemlaghi S, Dubée V, Lejour G, Baudel JL, Galbois A, Lavillegrand JR, Bigé N, Tahiri J, Leblanc G, Maury E, Guidet B, Ait-Oufella H.

Ann Intensive Care. 2016 Dec;6(1):63. doi: 10.1186/s13613-016-0164-2. Epub 2016 Jul 11.

24.

Routes of Synthesis of Carbapenems for Optimizing Both the Inactivation of L,D-Transpeptidase LdtMt1 of Mycobacterium tuberculosis and the Stability toward Hydrolysis by β-Lactamase BlaC.

Iannazzo L, Soroka D, Triboulet S, Fonvielle M, Compain F, Dubée V, Mainardi JL, Hugonnet JE, Braud E, Arthur M, Etheve-Quelquejeu M.

J Med Chem. 2016 Apr 14;59(7):3427-38. doi: 10.1021/acs.jmedchem.6b00096. Epub 2016 Mar 18.

PMID:
26937999
25.

Bactericidal and intracellular activity of β-lactams against Mycobacterium abscessus.

Lefebvre AL, Dubée V, Cortes M, Dorchêne D, Arthur M, Mainardi JL.

J Antimicrob Chemother. 2016 Jun;71(6):1556-63. doi: 10.1093/jac/dkw022. Epub 2016 Feb 29.

PMID:
26929268
26.

Large Cohort Study of Central Venous Catheter Thrombosis during Intravenous Antibiotic Therapy.

Guillet S, Zeller V, Dubée V, Ducroquet F, Desplaces N, Horellou MH, Marmor S, Ziza JM.

Antimicrob Agents Chemother. 2015 Oct 12;60(1):36-43. doi: 10.1128/AAC.00700-15. Print 2016 Jan.

27.

Seizures, Paraplegia, and Cough Unveiling Disseminated Tuberculosis.

Baudel JL, Dubée V, Palle J, Ait-Oufella H.

Am J Med. 2016 Jan;129(1):e5-6. doi: 10.1016/j.amjmed.2015.06.048. Epub 2015 Jul 29. No abstract available.

PMID:
26231171
28.

Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.

Soroka D, Li de la Sierra-Gallay I, Dubée V, Triboulet S, van Tilbeurgh H, Compain F, Ballell L, Barros D, Mainardi JL, Hugonnet JE, Arthur M.

Antimicrob Agents Chemother. 2015 Sep;59(9):5714-20. doi: 10.1128/AAC.00598-15. Epub 2015 Jul 6.

29.

Mutation landscape of acquired cross-resistance to glycopeptide and β-lactam antibiotics in Enterococcus faecium.

Sacco E, Cortes M, Josseaume N, Bouchier C, Dubée V, Hugonnet JE, Mainardi JL, Rice LB, Arthur M.

Antimicrob Agents Chemother. 2015 Sep;59(9):5306-15. doi: 10.1128/AAC.00634-15. Epub 2015 Jun 15.

30.

Impact of β-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus.

Dubée V, Soroka D, Cortes M, Lefebvre AL, Gutmann L, Hugonnet JE, Arthur M, Mainardi JL.

Antimicrob Agents Chemother. 2015 May;59(5):2938-41. doi: 10.1128/AAC.05080-14. Epub 2015 Mar 2.

31.

β-Lactamase inhibition by avibactam in Mycobacterium abscessus.

Dubée V, Bernut A, Cortes M, Lesne T, Dorchene D, Lefebvre AL, Hugonnet JE, Gutmann L, Mainardi JL, Herrmann JL, Gaillard JL, Kremer L, Arthur M.

J Antimicrob Chemother. 2015 Apr;70(4):1051-8. doi: 10.1093/jac/dku510. Epub 2014 Dec 18.

PMID:
25525201
32.

Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic.

Dhar N, Dubée V, Ballell L, Cuinet G, Hugonnet JE, Signorino-Gelo F, Barros D, Arthur M, McKinney JD.

Antimicrob Agents Chemother. 2015 Feb;59(2):1308-19. doi: 10.1128/AAC.03461-14. Epub 2014 Nov 24.

33.

[Infections associated with orthopaedic devices].

Dubée V, Zeller V, Fantin B.

Rev Prat. 2014 May;64(5):643-50. French.

PMID:
24923048
34.

Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum β-lactamase.

Lefort A, Chau F, Lepeule R, Dubée V, Kitzis MD, Dion S, Fantin B.

Int J Antimicrob Agents. 2014 Apr;43(4):366-9. doi: 10.1016/j.ijantimicag.2013.12.001. Epub 2013 Dec 11.

PMID:
24388117
35.

Characterization of broad-spectrum Mycobacterium abscessus class A β-lactamase.

Soroka D, Dubée V, Soulier-Escrihuela O, Cuinet G, Hugonnet JE, Gutmann L, Mainardi JL, Arthur M.

J Antimicrob Chemother. 2014 Mar;69(3):691-6. doi: 10.1093/jac/dkt410. Epub 2013 Oct 16.

PMID:
24132992
36.

In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex.

Lavollay M, Dubée V, Heym B, Herrmann JL, Gaillard JL, Gutmann L, Arthur M, Mainardi JL.

Clin Microbiol Infect. 2014 May;20(5):O297-300. doi: 10.1111/1469-0691.12405. Epub 2013 Nov 11.

37.

In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems.

Cordillot M, Dubée V, Triboulet S, Dubost L, Marie A, Hugonnet JE, Arthur M, Mainardi JL.

Antimicrob Agents Chemother. 2013 Dec;57(12):5940-5. doi: 10.1128/AAC.01663-13. Epub 2013 Sep 16.

38.

Chemical shift perturbations induced by the acylation of Enterococcus faecium L,D-transpeptidase catalytic cysteine with ertapenem.

Lecoq L, Bougault C, Triboulet S, Dubée V, Hugonnet JE, Arthur M, Simorre JP.

Biomol NMR Assign. 2014 Oct;8(2):339-43. doi: 10.1007/s12104-013-9513-3. Epub 2013 Aug 2.

PMID:
23907322
39.

Kinetic features of L,D-transpeptidase inactivation critical for β-lactam antibacterial activity.

Triboulet S, Dubée V, Lecoq L, Bougault C, Mainardi JL, Rice LB, Ethève-Quelquejeu M, Gutmann L, Marie A, Dubost L, Hugonnet JE, Simorre JP, Arthur M.

PLoS One. 2013 Jul 4;8(7):e67831. doi: 10.1371/journal.pone.0067831. Print 2013.

40.

Structure of Enterococcus faeciuml,d-transpeptidase acylated by ertapenem provides insight into the inactivation mechanism.

Lecoq L, Dubée V, Triboulet S, Bougault C, Hugonnet JE, Arthur M, Simorre JP.

ACS Chem Biol. 2013;8(6):1140-6. doi: 10.1021/cb4001603. Epub 2013 Apr 12.

41.

Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study.

Dubée V, Zeller V, Lhotellier L, Kitzis MD, Ziza JM, Mamoudy P, Desplaces N.

Clin Microbiol Infect. 2013 Feb;19(2):E98-105. doi: 10.1111/1469-0691.12071. Epub 2012 Dec 10.

42.

Three-month antibiotic therapy for early-onset postoperative spinal implant infections.

Dubée V, Lenoir T, Leflon-Guibout V, Briere-Bellier C, Guigui P, Fantin B.

Clin Infect Dis. 2012 Dec;55(11):1481-7. doi: 10.1093/cid/cis769. Epub 2012 Aug 31.

PMID:
22942207
43.

Inactivation of Mycobacterium tuberculosis l,d-transpeptidase LdtMt₁ by carbapenems and cephalosporins.

Dubée V, Triboulet S, Mainardi JL, Ethève-Quelquejeu M, Gutmann L, Marie A, Dubost L, Hugonnet JE, Arthur M.

Antimicrob Agents Chemother. 2012 Aug;56(8):4189-95. doi: 10.1128/AAC.00665-12. Epub 2012 May 21.

44.

Kinetic analysis of Enterococcus faecium L,D-transpeptidase inactivation by carbapenems.

Dubée V, Arthur M, Fief H, Triboulet S, Mainardi JL, Gutmann L, Sollogoub M, Rice LB, Ethève-Quelquejeu M, Hugonnet JE.

Antimicrob Agents Chemother. 2012 Jun;56(6):3409-12. doi: 10.1128/AAC.06398-11. Epub 2012 Mar 26.

45.

Inactivation kinetics of a new target of beta-lactam antibiotics.

Triboulet S, Arthur M, Mainardi JL, Veckerlé C, Dubée V, Nguekam-Moumi A, Gutmann L, Rice LB, Hugonnet JE.

J Biol Chem. 2011 Jul 1;286(26):22777-84. doi: 10.1074/jbc.M111.239988. Epub 2011 May 4.

46.

[Hypophosphatemia complicated with neurological manifestations during hematopoietic reconstitution].

Dubée V, Hermine O, Marçais A.

Rev Med Interne. 2012 Jan;33(1):e1-2. doi: 10.1016/j.revmed.2011.02.002. Epub 2011 Mar 9. French.

PMID:
21392866
47.

The in vitro contribution of autolysins to bacterial killing elicited by amoxicillin increases with inoculum size in Enterococcus faecalis.

Dubée V, Chau F, Arthur M, Garry L, Benadda S, Mesnage S, Lefort A, Fantin B.

Antimicrob Agents Chemother. 2011 Feb;55(2):910-2. doi: 10.1128/AAC.01230-10. Epub 2010 Nov 22.

48.

Flow cytometry as a tool to determine the effects of cell wall-active antibiotics on vancomycin-susceptible and -resistant Enterococcus faecalis strains.

Chau F, Lefort A, Benadda S, Dubée V, Fantin B.

Antimicrob Agents Chemother. 2011 Jan;55(1):395-8. doi: 10.1128/AAC.00970-10. Epub 2010 Oct 18.

Supplemental Content

Support Center